The promoter region of the AE4 gene22 (link) was amplified by PCR from mouse genomic DNA and cloned into the pGL3-Basic (pGL3b) vector (Promega). pGL3b-AE4 mutant constructs were generated by site directed mutagenesis of one or both TTT > GGG sequences in the promoter. N-terminal and C-terminal truncations of Foxi3 as well as full length (FL; 1–399) Foxi3 were amplified from pCMV-SPORT6-Foxi344 (link) and cloned in a 3XFLAG vector (Sigma). A Foxi3 FL NLS mutant construct was generated by site directed mutagenesis of the predicted nuclear localization sequence (NLS) in 3xFLAG Foxi3 FL. C-terminal Foxi3 fragments were amplified and cloned as a fusion construct with the DNA binding domain of GAL4 in pBIND vector (Promega). 9aaTAD Mut1 and 2 were generated by site directed mutagenesis of the predicted 9aaTAD in pBIND Foxi3 350–399 construct. PPP2R2A, PPP2CB, PPP2R1B was amplified by PCR using mouse cDNA and cloned in pCMV-Myc vector (Clontech). All cloning was performed with an In-Fusion HD Cloning kit (Clontech).
Free full text: Click here